OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes‐related and cancer outcomes
David R. Riley, Theresa Hydes, Gema Hernadez, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2538-2550
Open Access | Times Cited: 13
David R. Riley, Theresa Hydes, Gema Hernadez, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2538-2550
Open Access | Times Cited: 13
Showing 13 citing articles:
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Degraded sweet corn cob polysaccharides modulate T2DM-induced abnormalities in hepatic lipid metabolism via the bile acid-related FXR-SHP and FXR-FGF15-FGFR4 pathways
Weiye Xiu, Xin Wang, Zhiguo Na, et al.
Food Bioscience (2024) Vol. 62, pp. 105085-105085
Closed Access | Times Cited: 5
Weiye Xiu, Xin Wang, Zhiguo Na, et al.
Food Bioscience (2024) Vol. 62, pp. 105085-105085
Closed Access | Times Cited: 5
Alessandro Mantovani, Riccardo Morandin, Elena Sani, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 4
Association of changes in the type 2 diabetes and MASLD /related SLD status with risk of developing cardiovascular disease
Yasuhiro Matsubayashi, Kazuya Fujihara, LAY MON KHIN, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Yasuhiro Matsubayashi, Kazuya Fujihara, LAY MON KHIN, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Precise diabetes visualization designed for lipid droplet-targeted polarity-sensitive fluorescent probe
Xugong Yuan, Qian Zhang, Huawei Huang, et al.
Microchemical Journal (2025), pp. 113018-113018
Closed Access
Xugong Yuan, Qian Zhang, Huawei Huang, et al.
Microchemical Journal (2025), pp. 113018-113018
Closed Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Investigating hepatic steatosis: the MISHTI study (Multicentric cross-sectional Indian Study of Hepatic and Metabolic Trends in India)
Debasis Datta, Krishna Seshadri, Samit Ghosal
Research Square (Research Square) (2025)
Closed Access
Debasis Datta, Krishna Seshadri, Samit Ghosal
Research Square (Research Square) (2025)
Closed Access
Liver-related events and outcomes in patients with metabolic dysfunction-associated steatotic liver disease varies with the type of Cardiometabolic Risk Factor
Shekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102559-102559
Closed Access
Shekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102559-102559
Closed Access
Cardiovascular events, mortality, and incident type 2 diabetes in patients with metabolic dysfunction-associated steatohepatitis: a claims-based analysis of commercial and medicare advantage enrollees
Semiu O. Gbadamosi, Jason Swindle, Hai V. Nguyen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Open Access
Semiu O. Gbadamosi, Jason Swindle, Hai V. Nguyen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Open Access
Glucagon-Like Peptide-1 Receptor Agonists are Associated with Improved Survival and Reduced Liver-Related Events in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease: A Large Real-World Retrospective Study
Benjamin D. Liu, Mohammed Y. F. Aly, Cindy Hsin-Ti Lin, et al.
Endocrine Practice (2025)
Closed Access
Benjamin D. Liu, Mohammed Y. F. Aly, Cindy Hsin-Ti Lin, et al.
Endocrine Practice (2025)
Closed Access
Target Screening and Single Cell Analysis of Diabetic Retinopathy and Hepatocarcinoma
Y.-Y. Shao, B Duan, Haotian Li, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 9
Open Access
Y.-Y. Shao, B Duan, Haotian Li, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 9
Open Access
Targeting Metabolism: Innovative Therapies for MASLD Unveiled
Weixin Wang, Xin Gao, Wei Niu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4077-4077
Open Access
Weixin Wang, Xin Gao, Wei Niu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4077-4077
Open Access
Correlation Between Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Urinary Incontinence in Adult Women
Fan Zhang, Wenjian Li
International Journal of Women s Health (2024) Vol. Volume 16, pp. 1607-1624
Open Access | Times Cited: 1
Fan Zhang, Wenjian Li
International Journal of Women s Health (2024) Vol. Volume 16, pp. 1607-1624
Open Access | Times Cited: 1
Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
Yingying Zhang, Pingping Wang, Fan Tu, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yingying Zhang, Pingping Wang, Fan Tu, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men
Wen‐Rui Hao, Chun‐Han Cheng, Tzu-Hurng Cheng
World Journal of Cardiology (2024) Vol. 16, Iss. 9, pp. 502-507
Closed Access
Wen‐Rui Hao, Chun‐Han Cheng, Tzu-Hurng Cheng
World Journal of Cardiology (2024) Vol. 16, Iss. 9, pp. 502-507
Closed Access
